By vgreene, 19 June, 2019 CEBPA1,3 somatic mutations of the gene FLT3 (a receptor tyrosine kinase), NPM1, and CEBPalpha have been identifed as important prognostic factors in cytogenetically normal AML per ESMO;3
By vgreene, 19 June, 2019 NPM11,3 somatic mutations of the gene FLT3 (a receptor tyrosine kinase), NPM1, and CEBPalpha have been identifed as important prognostic factors in cytogenetically normal AML per ESMO;3
By vgreene, 19 June, 2019 FLT3 (ITD and TKD)1,3 somatic mutations of the gene FLT3 (a receptor tyrosine kinase), NPM1, and CEBPalpha have been identifed as important prognostic factors in cytogenetically normal AML per ESMO;3